NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024
Overview
Authors
Affiliations
The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma.
Huibers A, Leong S, Kashani-Sabet M, White Jr R, Vetto J, Schneebaum S Ann Surg Oncol. 2025; .
PMID: 40064798 DOI: 10.1245/s10434-025-17084-4.
Cheng J, Kang W, Chen Y, Pan L, Han H, Lv T Cancer Immunol Immunother. 2025; 74(4):124.
PMID: 39998635 PMC: 11861770. DOI: 10.1007/s00262-025-03958-9.
Resch E, Makri S, Ghanem P, Baraban E, Cohen K, Cohen A NPJ Precis Oncol. 2025; 9(1):48.
PMID: 39984702 PMC: 11845573. DOI: 10.1038/s41698-025-00826-8.
Restaino S, Pellecchia G, Arcieri M, Bogani G, Taliento C, Greco P Cancers (Basel). 2025; 17(2).
PMID: 39857968 PMC: 11764181. DOI: 10.3390/cancers17020186.
Sentinel Lymph Node Biopsy: Is There a Role in Non-Melanoma Skin Cancer? A Systematic Review.
Borgognoni L, Susini P, Gerlini G, Brandani P, Giannotti V, Sestini S Cancers (Basel). 2025; 16(24.
PMID: 39766177 PMC: 11674682. DOI: 10.3390/cancers16244279.